1991
DOI: 10.1097/00005344-199103000-00020
|View full text |Cite
|
Sign up to set email alerts
|

Modification of Circadian Blood Pressure and Heart Rate Variability by Five Different Antihypertensive Agents in Spontaneously Hypertensive Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
34
1
2

Year Published

1993
1993
2012
2012

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(44 citation statements)
references
References 0 publications
7
34
1
2
Order By: Relevance
“…Further studies with a larger sample size will be required to validate this finding. These findings are in contrast to limited data from the adult rat, which suggest that the SNS mediates the central SCN-driven diurnal rhythm in HR and MAP (17,48). A limitation of the present study is that the effect of the SNS and vagal input were tested separately.…”
Section: Discussioncontrasting
confidence: 74%
“…Further studies with a larger sample size will be required to validate this finding. These findings are in contrast to limited data from the adult rat, which suggest that the SNS mediates the central SCN-driven diurnal rhythm in HR and MAP (17,48). A limitation of the present study is that the effect of the SNS and vagal input were tested separately.…”
Section: Discussioncontrasting
confidence: 74%
“…However, this seems unlikely in view of the similar sociocultural background of patients and control subjects as well as the mild to moderate degree of renal failure that uncommonly interferes with physical activity. Also, a variety of evidence from adults with pacemakers or biventricular assist devices, pregnant women, and spontaneously hypertensive rats suggests that regulation of BP and HR rhythmicity involves separate physiologic mechanisms (31)(32)(33)(34). For example, early pharmacologic experiments by Parati at al.…”
Section: Discussionmentioning
confidence: 99%
“…In most cases, data on hormonal reflex responses are not reported, 10,[13][14][15][16][20][21][22] while the heart rate (HR) response has been reported as either increased 20 or unchanged. 21,22,15,16 Use of hydralazine as antihypertensive therapy in an obesity-hypertension model is further complicated by the fact that potential side effects are similar to physiological changes often seen in obesity (e.g., tachycardia and activation of the reninangiotensin system (RAS)). 9,23,24 Therefore, the purposes of this study were two-fold.…”
Section: Introductionmentioning
confidence: 99%